wpeebb6edf.png

pharmaceutical business development

CASE STUDIES

OUR SERVICES

A Romanian pharmaceutical company wanted business development support. Find out how we helped >>

 

A university wanted a commercial appraisal and valuation of an antibody technology. Find out more >>

 

A biotech company’s business development resources were stretched. Find out how we provided interim management support >>

 

The Government of Egypt wanted a thorough strategic review and benchmarking of their pharmaceutical industry. Find out more >>

 

More case studies >>

 

WHAT A SATISFIED CLIENT SAYS ABOUT US...

 

“Many thanks indeed for a superbly compiled commercial appraisal...I've never been less than fully satisfied with your superbly crafted reports.”  

 

Dr Albert Chan

Overseas Markets Director

Special Products Limited

wp4d260c75_0f.jpg
wpf15fc759.gif

© Estradia Consulting Limited 

wp7e88b104.png
wp978d2d37.png
wp0b81fced.png
wpb1b233a5.png
wpe4889b74.png
wp26f79f53.png
wp9dcbd79a.png
wp2e0e51b9.gif
wp4d0b2b68.png
wp4d0b2b68.png
wp4d0b2b68.png

RECENT PROJECTS

 

We have worked with many international clients ranging from individual entrepreneurs and small companies through to pharmaceutical companies and governments.  We always strive to add value with what we do and only take on projects where we have the experience and skills required.  Below are some examples of recent projects.

 

Case Study 5

 

An entrepreneur wanted to raise money to start a new respiratory products company.  She was an experienced medical doctor but had limited business skills.

 

We worked with her to help her to prepare a robust business plan, to budget for the business start-up and to plan for the longer term development of the business.  We also supported her presentation of the business case to potential investors.

 

Case Study 6

 

A small early stage company developing a novel vaccine technology wanted advice on the licensing terms for allowing manufacturers to access their technology.

 

We prepared a draft licensing agreement for the company highlighting the areas that they needed to focus on during their negotiations with manufacturers. Through our extensive contacts in the international licensing field we were able to benchmark expected fees for technology access.

 

More Case Studies >>

 

<< Back to previous Case Studies